[In vitro study on arsenic trioxide-inducing apoptosis in primary acute promyelocytic leukemie cells].
To illustrate mechanisms of arsenic trioxide(As2O3) in the treatment of acute promyelocytic leukemia (APL). Cell-DNA content distribution, CD11b and CD33 antigens and nitroblue tetrazolium (NBT) reduction were evaluated in fresh APL cells from six APL patients treated in vitro with As2O3. As2O3 had double effects on the cells inducing apoptosis and inducing partial differentiation at higher and at lower drug concentrations, respectively. As2O3 (0.1 approximately 2.0 micromol/L) could rapidly modulate and degrade APL-specific marker molecule PML-RARalpha protein, which could play an important role in the effects of As2O3 on APL cells. As2O3 had double effects (induction of apoptosis and partial differentiation) on APL cells through the modulation and degradation of PML-RARalpha proteins.